Understanding the Current Rating
The 'Hold' rating assigned to National Peroxide Ltd indicates a balanced view of the stock’s prospects. It suggests that while the company shows signs of improvement and potential, investors should maintain a cautious stance rather than aggressively buying or selling. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals.
Quality Assessment
As of 31 August 2026, National Peroxide’s quality grade remains below average. The company has experienced a negative compound annual growth rate (CAGR) of -1.79% in operating profits over the past five years, signalling challenges in sustaining long-term profitability. Additionally, the average Return on Equity (ROE) stands at a modest 2.75%, reflecting limited efficiency in generating profits from shareholders’ funds. These factors highlight structural weaknesses in the company’s core operations, which temper enthusiasm despite recent positive developments.
Valuation Perspective
Contrasting its quality concerns, National Peroxide’s valuation is currently attractive. The stock trades at a Price to Book (P/B) ratio of approximately 1, which is considered reasonable and below the average valuations of its peers in the commodity chemicals sector. This discount provides a margin of safety for investors. Furthermore, the company’s ROE has improved to 5.1% recently, supporting the notion that the stock is fairly valued relative to its earnings potential. The PEG ratio of 0.1 further indicates that the stock’s price growth is not overstretched compared to its earnings growth, making it an appealing option for value-conscious investors.
Financial Trend and Recent Performance
The financial trend for National Peroxide Ltd is very positive as of the current date. The company has demonstrated robust growth in net sales, with a 12.13% increase reported in the latest quarter ending June 2026. This quarter also marked the highest net sales figure at ₹96.07 crores. Profit before tax (PBT) excluding other income surged by 196.5% compared to the previous four-quarter average, reaching ₹6.70 crores. Similarly, profit after tax (PAT) grew by 104.6% to ₹6.61 crores. These consecutive positive quarterly results over the last three quarters underscore a turnaround in operational performance and profitability.
Stock returns have also been encouraging recently. As of 31 August 2026, the stock has delivered a 51.21% return over six months and a 35.71% gain year-to-date. The one-year return stands at 3.89%, reflecting some volatility but overall positive momentum. These figures suggest that the market is recognising the company’s improving fundamentals, although the stock price experienced a slight dip of 1.97% on the most recent trading day.
Technical Outlook
From a technical standpoint, National Peroxide Ltd exhibits a bullish trend. The stock’s price movements over the past month and quarter show consistent upward momentum, supported by positive volume and market sentiment. This technical strength complements the improving financial metrics and valuation appeal, providing additional confidence for investors considering a hold position.
Shareholding and Market Capitalisation
National Peroxide Ltd is classified as a microcap stock within the commodity chemicals sector. The majority shareholding is held by promoters, which often implies stable ownership and potential alignment with shareholder interests. However, microcap status also suggests higher volatility and liquidity risks, factors that investors should weigh alongside the company’s fundamentals.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
What the Hold Rating Means for Investors
For investors, the 'Hold' rating on National Peroxide Ltd suggests a cautious but optimistic stance. The company’s attractive valuation and improving financial trend provide reasons to maintain exposure, especially for those seeking value opportunities in the commodity chemicals sector. However, the below-average quality metrics and historical challenges in profitability advise against aggressive accumulation at this stage.
Investors should monitor the company’s ability to sustain its recent growth in sales and profits, as well as any further improvements in return ratios. The bullish technical signals may offer short- to medium-term trading opportunities, but the microcap nature of the stock warrants careful risk management. Overall, the current rating reflects a balanced view that recognises progress while acknowledging ongoing risks.
Summary of Key Metrics as of 31 August 2026
- Mojo Score: 63.0 (Hold Grade)
- Operating Profit CAGR (5 years): -1.79%
- Average ROE: 2.75%
- Latest Quarterly Net Sales: ₹96.07 crores (highest recorded)
- Quarterly PBT (excl. other income): ₹6.70 crores (+196.5% vs previous 4Q average)
- Quarterly PAT: ₹6.61 crores (+104.6% vs previous 4Q average)
- Price to Book Value: ~1 (attractive valuation)
- PEG Ratio: 0.1
- Stock Returns: 6M +51.21%, YTD +35.71%, 1Y +3.89%
In conclusion, National Peroxide Ltd’s current 'Hold' rating by MarketsMOJO reflects a nuanced assessment of its financial health, valuation, and market positioning as of 31 August 2026. Investors should consider this rating as a guide to maintain their holdings while closely watching for further developments that could influence the stock’s trajectory.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
